MedTech Solutions (WAR:MDT) Marketable Securities: zł0.00 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:MDT MedTech Solutions SA WAR:MDT
39 GF Score
Price zł0.48
GF Value zł0.04
Valuation Significantly Overvalued
! 10 Warning Signs
View Full Analysis

What is MedTech Solutions Marketable Securities?

MedTech Solutions WAR:MDT +15.24% 39 Marketable Securities is zł0.00 Mil as of Mar. 2026. GuruFocus rates WAR:MDT with a GF Score™ of 39/100 and a GF Value™ of zł0.04 (Significantly Overvalued). The stock has 10 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. MedTech Solutions's Marketable Securities for the quarter that ended in Mar. 2026 was zł0.00 Mil.

MedTech Solutions  (WAR:MDT) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

MedTech Solutions Marketable Securities Related Terms

MedTech Solutions Marketable Securities Historical Data

* Premium members only.

The historical data trend for MedTech Solutions's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MedTech Solutions Marketable Securities Chart

MedTech Solutions Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

MedTech Solutions Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
WAR:MDT
39GF Score
MedTech Solutions SA WAR:MDT
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MedTech Solutions Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of zł0.00 Mil mean?
MedTech Solutions (WAR:MDT) has a Marketable Securities of zł0.00 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on MedTech Solutions and its competitors.
Is MedTech Solutions' Marketable Securities too high?
MedTech Solutions' current Marketable Securities is zł0.00 Mil. Overall, MedTech Solutions has a GF Score™ of 39/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does MedTech Solutions' Marketable Securities compare to AMZN and BABA?
MedTech Solutions' Marketable Securities of zł0.00 Mil can be compared against companies in the Retail - Cyclical industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Retail - Cyclical company?
A good Marketable Securities depends on the Retail - Cyclical industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on MedTech Solutions and its competitors. MedTech Solutions's current Marketable Securities is zł0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedTech Solutions stock overvalued right now?
Based on GuruFocus' analysis, MedTech Solutions (WAR:MDT) is currently considered Significantly Overvalued. The stock's GF Value™ is zł0.04, compared to a current price of zł0.48 — trading 1110% above its estimated fair value. The current Marketable Securities is zł0.00 Mil. MedTech Solutions' overall GF Score™ is 39/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For MedTech Solutions (WAR:MDT), the current Marketable Securities is zł0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is MedTech Solutions (WAR:MDT) Overvalued in 2026?

Based on GuruFocus' analysis, MedTech Solutions stock appears to be overvalued. The current stock price of zł0.48 is trading 1110% above its estimated GF Value™ of zł0.04. GuruFocus considers MedTech Solutions to be Significantly Overvalued.

Key valuation signals for WAR:MDT:

  • Marketable Securities: zł0.00 Mil
  • GF Value™: zł0.04 vs. price of zł0.48 (1110% above fair value)
  • GF Score™: 39/100 with 10 warning signs

No single metric tells the full story. See the WAR:MDT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

MedTech Solutions Business Description

Address Dluga 29, Warsaw, POL, 00-238
MedTech Solutions SA formerly E-shopping Group SA main activity is based on conducting business through its own e-shops that operate in the dropshipping sales model.
39GF Score

Get the complete analysis for WAR:MDT

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł0.48
Price
zł0.04
GF Value